(Q39699823)

14 September 2017

title

Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling (English)

1 reference

14 September 2017

0 references

1 reference

S Drewlo

1

1 reference

14 September 2017

K Levytska

2

1 reference

14 September 2017

M Sobel

3

1 reference

14 September 2017

D Baczyk

4

1 reference

14 September 2017

S J Lye

5

1 reference

14 September 2017

J C P Kingdom

6

1 reference

14 September 2017

publication date

1 December 2011

1 reference

Journal of Thrombosis and Haemostasis

14 September 2017

published in

1 reference

14 September 2017

volume

9

1 reference

14 September 2017

issue

12

1 reference

14 September 2017

page(s)

2486-2497

1 reference

Latest advances in understanding preeclampsia

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

The frequency and severity of placental findings in women with preeclampsia are gestational age dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Placental expression of vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 correlates with severity of clinical preeclampsia and villous hypermaturity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Non-anticoagulant heparins and inhibition of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Promotion of trophoblast stem cell proliferation by FGF4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Heparin prevents programmed cell death in human trophoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Effect of heparin and fractionated heparin on trophoblast invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Local retention versus systemic release of soluble VEGF receptor-1 are mediated by heparin-binding and regulated by heparanase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Apoptosis and its role in the trophoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Phenotype and mRNA expression of syncytiotrophoblast microparticles isolated from human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Promotion of angiogenesis by human endometrial lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

The "Great Obstetrical Syndromes" are associated with disorders of deep placentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Local guidance of emerging vessel sprouts requires soluble Flt-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Aspirin plus heparin or aspirin alone in women with recurrent miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Use of low molecular weight heparin in pregnant women with mechanical heart valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

10.1111/J.1538-7836.2011.04526.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference